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Introduction
Organisms constantly combat environmental insults, which can denature proteins, destroy molecular function and rapidly result in toxic aggregates. Under these circumstances, quality-control networks in the cell attempt to refold damaged proteins (Visick and Clarke, 1995; Feder and Hofmann, 1999) . In Escherichia coli, the qualitycontrol network includes IbpA and IbpB, which are members of the small heat-shock protein family (sHSPs), as well as the energy-dependent chaperones GroEL/ GroES and DnaK/DnaJ/GrpE, and the ClpB disaggregase (Georgopoulos and Welch, 1993; Parsell and Lindquist, 1993; Lund, 2001) . Lon and other AAA+ (ATPases associated with various cellular activities) proteases also play a major role in clearing misfolded and damaged proteins from the cell. Recent work demonstrates that certain branches of the quality-control network can cooperate to refold damaged proteins (Mogk et al., 2003a,b; Doyle et al., 2007 ). Here we investigate a possible link between the protein degradation branch and the sHSP branch of the protein quality-control network.
The sHSPs are a family of ATP-independent molecular chaperones. Current studies indicate that sHSPs bind and function to protect misfolded proteins from irreversible aggregation (Laskowska et al., 1996; Lee et al., 1997; Narberhaus, 2002) . All sHSPs contain a central conserved a-crystallin domain flanked by N-and C-terminal tails of variable length and amino-acid composition (Haslbeck et al., 2005) . sHSPs exist as higher-order oligomers, a characteristic that is crucial for client-protein protection (Leroux et al., 1997; van de Klundert et al., 1998) .
Escherichia coli has two sHSPs, IbpA and IbpB, which are expressed from the same operon (Allen et al., 1992) . The Ibps are important for resistance to heat stress, as well as superoxide and copper-induced oxidative stress (Thomas and Baneyx, 1998; Kitagawa et al., 2000; Matuszewska et al., 2008) . Furthermore, IbpA and IbpB interact with each other at elevated temperatures in vitro and cooperate to keep client proteins in a refoldingcompetent state (Matuszewska et al., 2005) . After thermal inactivation, for example, luciferase is reactivated more efficiently by ClpB and DnaK/J/E in vitro, if both IbpA and IbpB are present during the initial thermal inactivation, than if only one of the Ibps is present (Ratajczak et al., 2009) . The Ibps also cooperate with ClpB and DnaK to reverse protein aggregation in vivo (Mogk et al., 2003a) . Thus, the Ibps interact functionally with the disaggregation and refolding machinery of the cell. However, to date, the Ibps have not been specifically linked to the proteindegradation machinery.
Lon is the principal protease responsible for the degradation of damaged and misfolded proteins in E. coli (Kowit and Goldberg, 1977; Fredriksson et al., 2005) . For example, Lon-deficient cells accumulate more aggregated proteins following heat shock than cells missing other AAA+ proteases (Tomoyasu et al., 2001; Rosen et al., 2002) . Recent work demonstrates that Lon can directly recognize misfolded substrates by binding to exposed hydrophobic regions, which would normally be buried in properly folded proteins (Gur and Sauer, 2008b) , providing insight into one mode by which Lon recognizes substrates.
In this study, we report that IbpA and IbpB are themselves substrates for Lon, suggesting that there is functional cross-talk between the sHSPs and the protein degradation machinery. We further demonstrate that the rates of degradation of the Ibps are controlled by their Nand C-terminal tails. Unexpectedly, however, these tails are not required for Lon recognition. Rather, they influence the maximal speed of Lon proteolysis. Finally, we show that the presence of IbpB accelerates the rate of Lon degradation of IbpA both in vitro and in vivo. Our results therefore provide a new link between the sHSP and the protein-degradation branches of the qualitycontrol network and further suggest a distinct method of substrate recognition by Lon.
Results

The E. coli sHSPs IbpA and IbpB are Lon substrates
IbpA and IbpB were initially identified in a proteomic screen for substrates of E. coli Lon protease (E. Oakes and TAB, pers. comm.), using a strategy similar to previous screens for ClpXP substrates (Flynn et al., 2003; Neher et al., 2006) . Briefly, Lon carrying an active-site mutation was used to trap substrates in vivo (Van Melderen and Gottesman, 1999) , and the trapped substrates were identified by mass spectrometry. Approximately 200 potential Lon substrates were identified as high-quality Lon-interacting proteins using this method. To determine directly whether IbpA and IbpB are substrates for Lon, we purified 35 S-labelled IbpA and IbpB and measured the rate at which Lon proteolysis generated acid-soluble radioactive peptides. Both proteins were degraded by Lon (Fig. 1B) . However, despite the fact that IbpA and IbpB are approximately 50% identical at the sequence level (Fig. 1A) , Lon degraded IbpB much faster than IbpA (Fig. 1B) .
This difference in degradation rates could result from altered Lon recognition, which would be reflected in different KM values for proteolysis. Alternatively (or in addition), Lon processing of IbpA and IbpB might differ at a downstream step, such as substrate unfolding or translocation, leading to differences in Vmax. To distinguish between these possibilities, we determined steady-state rates of degradation of varying concentrations of IbpA and IbpB by Lon and fit these data to the Michaelis-Menten equation (Fig. 1C) . Interestingly, the K M values for Lon degradation of IbpA and IbpB were nearly identical (16-18 mM). However, the Vmax for IbpB degradation was almost 15-fold higher than that of IbpA ( Fig. 1C ; Table 1 ). Thus, Lon recognizes IbpA and IbpB as substrates equally well but processes IbpB much faster than IbpA.
Ibp tails are not required for Lon recognition
The degradation determinants of AAA+ protease substrates are often (although not always) found near the very N-or C-terminus of the substrate (Tobias et al., 1991; Gottesman et al., 1998; Flynn et al., 2003) . Furthermore, the N-and C-terminal tails of sHSPs are known to be important for oligomerization and client-protein protection (Fernando and Heikkila, 2000; Jiao et al., 2005b (Table 1) . Once again, differences in the rates of Lon degradation were completely attributable to differences in Vmax values ( Fig. 2B and C ; Table 1 ). These experiments demonstrate that the N-and C-terminal tails of the Ibps are dispensable for Lon recognition. Thus, unlike other specific substrates of Lon, the Ibps are recognized via sequence or structural determinants in the body of the protein, specifically, within the a-crystallin domains of the Ibps.
Lon degrades human a-crystallin domains
Our results with the tail-less Ibps clearly indicate that Lon recognizes a region within the a-crystallin domains of the Ibps. We hypothesized that Lon recognizes a feature of the natively folded a-crystallin domain and might therefore degrade other a-crystallin proteins. To test this model, we purified full-length versions of two human a-crystallin proteins, aA-crystallin (haA) and aB-crystallin (haB), as well as the tail-less a-crystallin domains of these proteins (haA a and haB a ), and assayed degradation by Lon in vitro ( Fig. 3B and C ; Table 1 ). Strikingly, haA a and haB a were both excellent Lon substrates. Indeed, the second-order rate constants (Vmax/KM) for Lon degradation of these a-crystallin domains were twofold to fourfold larger than the value for IbpB, which was the best Lon substrate among the full-length and tail-less Ibp proteins. Furthermore, although the Vmax values for Lon degradation of human aA, aB, aA a and aB a differed substantially (0.06-3.8 min -1 Lon6
; Table 1 ), the KM values were similar (26-58 mM). These experiments establish that Lon can degrade a-crystallin domains that are only distantly related to the Ibps (Fig. 3A ) and support our hypothesis that Lon may recognize a feature of the folded a-crystallin domain.
It is possible that the native and denatured forms of the a-crystallin domain are in dynamic equilibrium and that Lon recognizes a peptide sequence in the unfolded protein. However, given that all of these variants contain the same modular fold, but different amino-acid sequences, and were all degraded with similar K M values, we consider it more likely that Lon recognizes a general characteristic of the folded a-crystallin domain. , KM = 16 Ϯ 2.7 mM). Degradation rates were measured from experiments like the one shown in (B) and were fit to the Michaelis-Menten equation. Error bars (Ϯ1 SD) in this and all other figures were calculated from at least three independent experiments. The large error in the KM for IbpA is due to the slow rate of degradation. Inset: The IbpA data are replotted on an expanded scale to show the curvature of the fitted line. 
The oligomeric-states of full-length and tail-less a-crystallin proteins do not correlate with their rates of degradation
The ability to form higher-order oligomers is thought to be of crucial importance for sHSPs to perform their chaperone functions (Fernando and Heikkila, 2000) . Furthermore, oligomerization is disrupted by deletions in the Nand C-terminal tails of sHSPs (Fernando and Heikkila, 2000; Jiao et al., 2005b) . To investigate the possible relationship between the oligomeric state of the Ibps/human a-crystallin proteins and their rates of degradation by Lon, we performed gel-filtration analysis on full-length and tailless IbpB (Fig. 4A ) and full-length and tail-less human aB-crystallin (Fig. 4B) . Consistent with previous reports, we found that tail-less versions of both IbpB and aB-crystallin eluted as much smaller complexes than the full-length proteins. However, although IbpB a is only degraded one-third as fast as full-length IbpB, aB a is degraded over 60 times faster than full-length aB-crystallin (Figs 2C and 3C; Table 1 ). Thus, we find that Lon is able to degrade both highly oligomerized versions of a-crystallin proteins (IbpB), as well as smaller oligomeric versions of a-crystallin proteins (aB a ) in a robust manner. Therefore, differences in multimeric state do not explain how the tails of the Ibps/a-crystallin proteins control their rate of degradation.
IbpB facilitates Lon degradation of IbpA in vivo and in vitro
IbpA and IbpB interact and cooperate to perform chaperone functions (see Introduction and Matuszewska et al., 2005) . To investigate potential synergy in degradation, we assayed Lon degradation of 35 S-IbpA in the presence of unlabelled IbpB and vice versa. Importantly, the rate of IbpA degradation increased sevenfold in the presence of equimolar IbpB, indicating that IbpB facilitates Lon degradation of IbpA. In contrast, the rate of IbpB degradation decreased twofold in the presence of equimolar IbpA (Fig. 5A) .
To determine if IbpB alters Lon degradation of IbpA in vivo, we measured the intracellular turnover of IbpA in the presence or absence of IbpB at 45°C, where both proteins are expressed at reasonably high levels (Laskowska et al., 1996) . IbpA was degraded with a half-life of about 15 min in a lon + strain but was completely stabilized in an otherwise isogenic lon -strain (Fig. 5B , top panel and 5C), supporting the idea that under these conditions, Lon is the predominant protease responsible for IbpA degradation in vivo. Furthermore, in complete agreement with our experiment in vitro (Fig. 5A) , IbpA was also stabilized in an ibpB -lon + strain (Fig. 5B , bottom panel and 5C), indicating that both IbpB and Lon are essential for efficient intracellular degradation of IbpA. Because our IbpB antibody was not as sensitive as the IbpA antibody, we were unable to detect endogenous levels of IbpB, even after heat shock. However, in a strain lacking chromosomal ibpAB, overexpressed IbpB was degraded in a largely Lon-dependent manner (data not shown), consistent with the fact that Lon degrades IbpB in the absence of IbpA in vitro. These degradation results in vivo are also consistent with the finding that IbpA and IbpB were both recovered in substrate-trapping experiments with proteolytically inactive Lon (E. Oakes and TAB, pers. comm.). Thus, we 
Discussion
In this work, we demonstrate that Lon degrades the E. coli sHSPs, IbpA and IbpB. Unlike other specific Lon substrates (non-damaged proteins) whose recognition determinants are at the far N-or C-terminus of the substrate, the Lon-recognition determinants of the Ibps are located within the core a-crystallin domains of the Ibps. However, the N-and/or C-terminal tails of the Ibps play a critical role in controlling their rates of degradation. Interestingly, this control is manifested as a difference in the maximum rate of Ibp degradation and not as a difference in K M. Finally we show that IbpA is degraded more efficiently by Lon when IbpB is present both in vitro and in vivo.
Lon recognition of Ibps
AAA+ proteases typically recognize peptide signals near the N-or C-termini of substrates (Tobias et al., 1991; Gottesman et al., 1998; Flynn et al., 2003) , and Lon can also choose substrates by interacting with specific peptide signals (Gonzalez et al., 1998; Ishii and Amano, 2001; Shah and Wolf, 2006; Choy et al., 2007; Gur and Sauer, 2008a,b) . However, neither IbpA nor IbpB contain an obvious sequence that resembles well-characterized Lon degradation tags. Instead, we propose that Lon recognizes a portion of the folded a-crystallin domains of IbpA , KM = 26 Ϯ 12 mM). Insets: The data for haA and haB are replotted on expanded scales.
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and IbpB (Fig. 6A) . This model explains our findings that Lon degrades the full-length Ibps, their tail-less a-crystallin domains, as well as human aA-crystallin and aB-crystallin and their tail-less counterparts. Furthermore, in each case, the KM values for these degradation reactions ranged from 15 to 60 mM ( Table 1 ), suggesting that Lon recognizes these variants with similar affinities. An alternative model is that Lon recognizes a common peptide motif within these a-crystallin domains. However, this mechanism is unlikely given the lack of similarity between the amino-acid sequences of these proteins (Fig. 3A) . Moreover, human mitochondrial Lon degrades the folded form of the a-subunit of mitochondrial processing peptidase more efficiently than it degrades the unfolded form of this substrate (Ondrovicová et al., 2005) , providing a precedent for Lon recognition of a structural feature of a folded domain.
The tails of IbpA and IbpB control the rate of Lon degradation
Interestingly, the V max values for Lon degradation of different variants of IbpA, IbpB, aA-crystallin and aB-crystallin varied substantially, in some cases by more than 50-fold (Table 1) . Moreover, the tails of IbpA, aA-crystallin and aB-crystallin slow degradation, whereas the tails of IbpB facilitate degradation. Although the tails of sHSPs are known to affect sHSP oligomerization, we found no correlation between the oligomeric state of Ibp/a-crystallin and their rate of degradation (Figs 2C, 3C and 4) . This ability of the protein tails to alter the maximal rate of degradation is unusual, as degradation by AAA+ proteases is usually regulated at the level of recognition (for review, see Baker and Sauer, 2006) . However, recent studies show that model substrates can programme the speed and efficiency of degradation by Lon (Gur and Sauer, 2009 ). The Ibps therefore appear to be examples of biological Lon substrates whose degradation can be controlled in this manner.
IbpB activates Lon degradation of IbpA
Our studies show that IbpB facilitates Lon degradation of IbpA both in vitro and in vivo (Fig. 5) . This apparent interaction parallels the ability of IbpA and IbpB to cooperate in performing their chaperone activity in vitro (Matuszewska et al., 2005; Ratajczak et al., 2009) . However, to our knowledge, cooperation of any kind between endogenous IbpA and IbpB in vivo has not previously been described. It remains to be determined whether IbpB-controlled degradation of IbpA by Lon serves a regulatory role or is related, in some fashion, to chaperone activities in vivo.
Furthermore, although the rate of IbpB-stimulated IbpA degradation in vivo is slow compared with the degradation of some of the well-characterized Lon substrates [t 1/2-15 min compared with 2 min for SoxS and 1.2 min for SulA (Mizusawa and Gottesman, 1983; Griffith et al., 2004) ], there are other examples of biologically important substrates of AAA+ proteases with long half-lives. For example, in minimal media, the half-life of UvrA, the nucleotide excision repair protein and ClpXP substrate, is 70 min (Pruteanu and Baker, 2009) .
Despite the relatively slow degradation of the Ibps, the connections between the assembled Ibps and Lon suggest that there may be functional cross-talk between the sHSPs and the protein-degradation machinery. For example, IbpA and IbpB may be degraded by Lon as they cooperate to help Lon recognize and degrade damaged proteins, which cannot be refolded (Fig. 6B ). In this model, IbpA and IbpB act analogously to the Bacillus subtilis MecA adaptor protein, which facilitates the degradation of unfolded and aggregated substrates by the protease ClpCP in vitro and is itself degraded in the process (Turgay et al., 1998; Schlothauer et al., 2003) . We propose that Lon also degrades free Ibps to keep their concentrations low during non-stress conditions, or during return to normal conditions following heat shock, when Ibp Unfolded client levels rapidly decrease (Mogk et al., 2003a; Jiao et al., 2005a) . In this case, Lon degradation of unneeded Ibps might serve to prevent spurious Ibp binding to functional proteins. Interestingly, we found that IbpA is degraded robustly by Lon under heat stress in vivo ( Fig. 5B and C) , when the Ibps would be expected to be bound to client proteins (Laskowska et al., 1996) . As discussed above, the Ibps might deliver bound client proteins to Lon and be degraded in the process (Fig. 6B, pathway 2) . Several reports demonstrate the involvement of eukaryotic sHSPs in delivering specific clients for degradation (den Engelsman et al., 2003; Parcellier et al., 2003; Lin et al., 2006; Ahner et al., 2007) , and prokaryotic sHSPs may play a similar role. Alternatively, degradation of client-bound Ibps might be required to remove the Ibps and thus to facilitate clientprotein refolding (Fig. 6B, pathway 3) . In vitro, ClpB greatly accelerates DnaK/J/E-mediated refolding of sHSP-bound aggregated proteins, probably by disaggregating sHSPclient complexes (Mogk et al., 2003b; Ratajczak et al., 2009) . As our results suggest that Lon can degrade clientbound Ibps in vivo (Fig. 5B) , Lon may also contribute to enhanced refolding of client proteins by removing bound Ibps. Consistently, preliminary experiments suggest that Lon degrades client-bound Ibps but not Ibp-bound clients in vitro (data not shown). Experiments to more completely investigate this model are underway.
Finally, our results demonstrate that IbpB is required for the efficient degradation of IbpA (Fig. 5) . Because IbpA and IbpB are co-transcribed, IbpA is expected to be translated first. As a result, a mechanism could have evolved to prevent Lon degradation of IbpA before it binds to its partner, IbpB. By this model, IbpA degradation is unlikely to simply be a way to clear unassembled subunits but rather is likely to serve an important functional role. Further experiments will be needed to interrogate models for the biological roles of the Ibp-Lon collaboration.
Experimental procedures
Protein purification
All Ibp and human a-crystallin proteins were purified using a method modified from Malakhov et al. (2004) . The human a-crystallin constructs were a gift from Ligia Acosta-Sampson and Jonathan King, MIT. His-SUMO fusions of each gene were cloned downstream of the T7 promoter and expressed in BL21 Dibp::kan. Cultures of each strain (1 l) were grown in Luria-Bertani (LB) broth at 37°C, induced at OD600 0.8 with 0.5 mM IPTG, grown for an additional 3 h at 30°C, harvested and stored frozen at -80°C until purification. Cells were thawed, resuspended in 3 ml of 50 mM HEPES-KOH (pH 8.0), and 0.5 ml of the nuclease Benzonase (Novagen) was added. The cells were lysed in a cell disruptor (Constant Systems) at 25 MPa, 10 ml of lysate dilution buffer (50 mM HEPES-KOH [pH 8.0], 4.5 M urea, 1.5 mM b-mercaptoethanol [BME], 600 mM potassium glutamate) was added, the lysate was cleared by centrifugation at 30000 ¥ g for 20 min, and the supernatant was incubated with 2 ml Ni-NTA beads (Qiagen) for 30 min at 4°C. The beads were packed in a column, rinsed with 250 ml LG-5 buffer (50 mM HEPES-KOH [pH 8.0], 4 M urea, 1 mM BME, 400 mM potassium glutamate, 5 mM imidazole) followed by 250 ml LG-20 buffer (identical to LG-5 buffer except with 20 mM imidazole). The protein was eluted with 10 ml elution buffer (50 mM HEPES-KOH [pH 8.0], 3 M urea, 1 mM BME, 400 mM potassium glutamate, 500 mM imidazole, 10% glycerol). Peak fractions were pooled and dialysed overnight against 2 l of dialysis buffer 1 (50 mM HEPES-KOH [pH 8.0], 2 M urea, 10% glycerol, 200 mM potassium glutamate, 1 mM BME). The His-SUMO domain was cleaved off by incubating the dialysed protein with 100 ml of ULP protease (purified as in Malakov et al. (2004) ) for 6 h at 37°C. The protein was then flowed over 2 ml of packed Ni-NTA beads, and the flowthrough fraction was collected and dialysed against 2 l of dialysis buffer 2 (50 mM HEPES-KOH [pH 8.0], 800 mM potassium glutamate, 20% sucrose, 1 mM BME). The molecular weight of each protein was confirmed by MALDI mass spectrometry.
35 S-labelled versions of substrates were expressed and purified as follows. Cultures of 100 ml were grown in LB broth at 37°C to an OD600 of 1.0. Cells were harvested and resuspended in 100 ml of M9 media supplemented with MAM and grown for an additional 15 min at 37°C. Cultures were induced with 0.5 mM IPTG and grown for an additional 20 min.
35 S-methionine (3.5 mCi) was added, the culture was grown for 3.5 h at 37°C, and the cells were harvested and subsequently resuspended in 3 ml of 50 mM HEPES-KOH (pH 8.0). Lysozyme was then added to a final concentration of 0.3 mg ml -1 , the cells were incubated on ice for 20 min, and then frozen at -80°C until purification.
35 S-labelled proteins were purified essentially as described above. Lon was purified using the procedure of Gur and Sauer (2008b) .
The isolated a-crystallin domains of IbpA, IbpB, aA-crystallin and aB-crystallin consisted of the following residues: IbpA (40-123), IbpB (36-121), aA-crystallin (63-145), aB-crystallin (67-149). A methionine was added to the N-terminus of each of these constructs to facilitate labelling with 35 S-methionine.
Degradation in vitro
Degradation of substrates in vitro was performed using 600 nM Lon6 in 50 mM Tris (pH 8.0), 15 mM MgCl2, 5 mM KCl, 1 mM DTT, 2% DMSO, 25 mM HEPES-KOH (pH 8.0), 400 mM potassium glutamate, 10% sucrose and 0.5 mM BME. Lon and substrate were incubated at 37°C for 2 min before the addition of the ATP-regeneration mix (32 mM ATP, 400 mg ml -1 creatine kinase, 40 mM creatine phosphate). Time points were taken every 30 s for 2.5 min, or every 5 min for 30 min. Reactions were quenched in 10% trichloroacetic acid (TCA). The TCA-insoluble material was removed by centrifugation and 35 S radioactivity in the supernatant was measured in a Tri-Carb liquid scintillation counter (Perkin Elmer). The fraction of substrate that had been degraded at each time point was calculated by dividing the TCA-soluble counts by the total counts in an equal volume of each reaction.
Determination of oligomeric-state by gel-filtration chromatography
Samples of IbpB, IbpB a , aB-crystallin or aB a (70 mM in 50 ml) were loaded onto a Tosoh Super SW 3000 HPLC column (pre-equilibrated with a buffer containing 50 mM HEPES-KOH [pH 8.0], 300 mM potassium glutamate) and eluted at a flow rate of 0.3 ml min -1 . Peaks were detected by absorbance at 280 nm or 213 nm. A mix of molecular-weight standards (Bio-Rad), which included thyroglobulin (670 kDa), g-globulin (158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa) and vitamin B12 (1.35 kDa), was chromatographed under the same conditions.
Antibody production
Polyclonal antibodies specific to IbpA and IbpB were generated by inoculating rabbits with a peptide specific to IbpA (RVIPEAKKPRRIEIN) or IbpB (IDLIRNEPEPIAAQR). Antibodies were produced by Covance Research Products.
Degradation in vivo
For degradation assays in vivo, a 60 ml culture in LB broth was grown at 37°C in a shaking water bath to OD600 0.2. The culture was then subjected to 45°C heat shock for 30 min before a 900 ml aliquot of the culture was added to 100 ml 100% TCA for the t = 0 sample. Spectinomycin was then added (to 400 mg ml -1 ), and samples were taken at 15 min intervals for 60 min. For each sample, OD600 was determined, and then TCA was added to a final concentration of 10%. The cultures were maintained at 45°C during the time-course. Samples were recovered by centrifugation and the pellets were rinsed with acetone and resuspended in enough 2X Tris-tricine sample buffer so that each sample contained the same cell density. An equal volume of each sample was run on a 16.5% Tris-tricine polyacrylamide gel. IbpA levels were detected using the anti-IbpA antibody described above and were quantified using ImageQuant software (GE Health Sciences).
